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Alternative splicing in eukaryotes plays an important role in regulating gene expression by
selectively including alternative exons. A wealth of information has been accumulated that
explains how alternative exons are selected in a developmental stage- or tissue-speciﬁc
fashion. However, our knowledge of how cells respond to environmental changes to alter
alternative splicing is very limited. For example, although a number of alternative exons
have been shown to be regulated by calcium level alterations, the underlying mechanisms
are not well understood. As calcium signaling in neurons plays a crucial role in essential
neuronal functions such as learning and memory formation, it is important to understand
how this process is regulated at every level in gene expression. The signiﬁcance of the
dynamic control of alternative splicing in response to changes of calcium levels has been
largely unappreciated. In this communication, we will summarize the recent advances in
calcium signaling-mediated alternative splicing that have provided some insights into the
important regulatory mechanisms. In addition to describing the cis-acting RNA elements
on the pre-mRNA molecules that respond to changes of intracellular calcium levels, we will
summarize how splicing regulators change and affect alternative splicing in this process.
We will also discuss a novel mode of calcium-mediated splicing regulation at the level of
chromatin structure and transcription.
Keywords: alternative splicing, depolarization, RNA-binding proteins, chromatin, histone modiﬁcation, transcrip-
tional elongation
Calcium signaling plays a pivotal role in many functions of the
cell at the molecular level. It is particularly important in neu-
rons for expression of genes essential for learning and memory
formation, and disruption of calcium signaling can cause neu-
ronal cell death leading to loss of memory (reviewed inWest et al.,
2001; Berridge, 2009). In neurons, changes in intracellular cal-
cium levels cause changes in membrane potential that control
neuronal excitability (reviewed in Berridge, 1998). Many stud-
ies have demonstrated that calcium signaling can regulate gene
expression at the transcription level (reviewed in Zhang et al.,
2009; Alonso and Garcia-Sancho, 2011). However, a number of
recentstudiesarerevealinganintriguingnewpost-transcriptional
level of regulation by calcium signaling: at the level of alternative
pre-mRNA splicing. It has been observed that an alteration of the
intracellular calcium level can lead to differential expression of
numerous alternative exons (reviewed in Xie, 2008). These obser-
vations have very signiﬁcant implications in terms of the dynamic
control of alternative splicing.
Morethan95%oftheprotein-codinggenesinhumansundergo
alternative splicing to provide a varied proteome (Pan et al.,2008;
Wangetal.,2008).Studiescarriedoutduringthelastthreedecades
have generated a wealth of information that contributes to our
understanding of cell type- and developmental stage-speciﬁc reg-
ulationofalternativesplicing.However,weknowsurprisinglylittle
abouthowcellsrespondtostimulitomodulatealternativesplicing.
Only a handful of studies have explored the underlying mecha-
nisms by which calcium signaling regulates alternative splicing.
A review published in 2008 provided a comprehensive summary
of calcium-mediated splicing control (Xie, 2008). In this review,
the author compiled a list of nearly 20 alternative exons that were
demonstrated to undergo calcium-mediated regulation. Next, he
discussed the potential mechanisms of calcium-mediated splicing
control using three well-studied examples. Finally, he speculated
how calcium signaling inﬂuences neuronal functions and dis-
ease development. Since 2008, several more studies have been
published, one of which demonstrated an exciting new level of
regulation. The current review is aimed at providing an in-depth
discussionofthemolecularmechanismsofthedynamiccontrolof
alternative splicing regulated by calcium signaling. An important
goal is to draw attention to this under-explored area of research.
Buildingoninformationgainedfromalimitednumberof studies,
we will point out important future directions.
REGULATION OF ALTERNATIVE SPLICING
Production of protein-coding mRNAs in mammalian cells
involves two tightly coupled processes: transcription of the pre-
mRNA from the gene and pre-mRNA processing, which consists
of 5  end capping, removal of introns, and polyadenylation of the
3  end of the pre-mRNA. RNA processing factors are loaded onto
the pre-mRNA co-transcriptionally,some through the C terminal
domain (CTD) of the largest subunit of RNA polymerase II (RNA
PolII)(MisteliandSpector,1999;HiroseandManley,2000;Lewis
andTollervey,2000;Phatnanietal.,2004;RosoninaandBlencowe,
2004; Bentley, 2005; Egloff and Murphy, 2008). The classical view
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of alternative splicing regulation involves short conserved RNA
sequences (enhancers and silencers) found in exons and introns
of the pre-mRNA molecule, where splicing regulators such as
serine/arginine proteins (SR proteins) and heterogeneous ribonu-
cleoproteins (hnRNPs) bind (reviewed in Black, 2003; Jurica and
Moore,2003). Upon binding to an enhancer or silencer sequence,
the splicing regulators either recruit the spliceosome, the basal
splicingmachinery,toorpreventthespliceosomefrominteracting
with a particular splice site to regulate the associated alternative
exon. Many splicing regulators are tissue-speciﬁc and hence are
thoughttobeimportantinprovidingdevelopmentalstage-speciﬁc
and functional isoforms of proteins for a particular tissue (Black,
2003; Grosso et al.,2008).
Inadditiontoregulationbysplicingfactors,alternativesplicing
canbecontrolledbytherateof transcriptionaswasﬁrstshownby
celltransfectionexperiments.Achangeintherateof RNAsynthe-
sisprovidesachangeinthesecondarystructureof thepre-mRNA,
which in turn affects the splicing event (Eperon et al., 1988). This
was conﬁrmed when different levels of alternative exon inclusion
were observed for the same gene using promoters of different
strengths to drive transcription. To explain the effects on alter-
native splicing by transcription, two models have been proposed
in the literature: the recruitment model and the kinetic coupling
model.Therecruitmentmodelsuggeststhatsplicingregulatorsare
recruited to pre-mRNA through their association with the tran-
scription machinery, in particular the CTD of Pol II, to regulate
splicing choices, whereas the kinetic model suggests that splicing
is controlled by the rate of elongation of Pol II. The slower rate of
transcription elongation allows more time for the usage of weak
splice sites (reviewed in Kornblihtt, 2005; Allo et al., 2011; Luco
et al.,2011).
The rate of elongation of transcription is thought to be con-
trolled by chromatin structure and the level of compaction of
the intragenic regions. The following recent studies support an
emerging idea that chromatin structure and histone modiﬁca-
tions are major contributors in regulation of alternative splicing
events (Allo et al., 2011; Luco et al., 2011). First, nucleosomes
were found to be enriched on exons as compared to introns by
analysisusingthedeepsequencingtechniqueincombinationwith
computational predictions (reviewed in Kaplan, 2009; Kornblihtt
et al., 2009; Schor et al., 2010). The general hypothesis is that the
nucleosomes provide a “roadblock or speed bump” for RNA Pol
II elongation, which in turn provides more time for the splic-
ing machinery to recognize alternative exons (Allo et al., 2011;
Luco et al., 2011). In addition to the exon deﬁnition concept
(Berget, 1995), where the splicing machinery recognizes intron–
exonboundariesbyphysicallyinteractingwiththesplicesites,this
isthoughttoprovideanothermodeof controlattheDNAlevelfor
splice site recognition. Support for this hypothesis came from the
observation that there is an enrichment of RNA Pol II at alterna-
tively spliced exons in comparison to constitutive exons, thereby
providing the splicing machinery more time to access weak splice
sites present at the alternative splice sites (Brodsky et al.,2005).
Secondly, chromatin immunoprecipitation (ChIP) studies
indicate that exons are differentially marked with speciﬁc his-
tonemodiﬁcationssuchastrimethylationof lysine36of histone3
(Kolasinska-Zwierz et al.,2009; Spies et al.,2009). Thirdly,studies
havedemonstratedthatspeciﬁchistonemarkscanrecruitsplicing
factors to the transcription site. For example, H3K4me3 recruits
the U2 snRNP, a component of the spliceosome, via the CHD1
protein that interacts with the histone mark (Sims et al.,2007). In
addition, H3K9me3 recruits hnRNPs through the HP1 proteins
in Drosophila (Piacentini et al., 2009). These studies indicate that
histone modiﬁcations can have a direct impact on splicing factor
recruitment. Lastly, a very recent study indicates that Hu pro-
teins, upon binding to their target sequences on the pre-mRNA,
inﬂuence the acetylation status of histones H3 and H4 leading
to a localized change in transcription elongation rate that further
impactsexonskippingofatleasttwoalternativeexons(Zhouetal.,
2011).
CALCIUM AND SPLICING
Several studies have shown that disturbance of the physiolog-
ical balance of calcium can contribute to alterations of alter-
native splicing events, especially in neuronal cells which have
the most diverse RNA population (Xie and Black, 2001; Black
and Grabowski, 2003; An and Grabowski, 2007; Lee et al., 2007;
Schor et al., 2009). In each of these studies, depolarization was
inducedincellswithintroductionof highextracellularpotassium,
which triggers calcium signaling by opening voltage-dependent
calcium channels (Figure1). An increase in internal calcium level
causes skipping of exon 5 and exon 21 of NMDA receptor type
1 (NMDAR1) in hippocampal neurons (Han et al., 2005; An and
Grabowski,2007;Leeetal.,2007)aswellastheSTREXexonof the
FIGURE 1 | Stimulation of a cell using various drugs can increase or
decrease intracellular calcium by affecting various channels and
pumps associated with calcium inﬂux. Increase in intracellular calcium
activates calcium/calmodulin-dependent kinases, which inﬂuence splicing
and/or localization of several splicing factors.These splicing factors can in
turn regulate splicing by binding to CaRREs or UAGG motifs in the
pre-mRNA. In addition, CaMK can phosphorylate protein kinases A and C,
which feed into the downstream MAPK pathway, eventually
phosphorylating ERK. Phosphorylated ERK plays a role in hyperacetylation
of histones H2B, H3, and H4, which affects splicing by controlling the rate
of transcription. CaMK also increases trimethylation of histone H3K36 at
speciﬁc exons, although the mechanism by which CaMK does it is not
known.The increase in trimethylation of histone H3K36 can directly affect
splicing by recruiting splicing factors.
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BK channel in GH3 pituitary cells (Xie and Black, 2001). These
twosplicingevents,whichareregulatedbycalciumsignaling,have
been studied in much detail and the results have provided impor-
tantinsightsintohowsplicingregulationbycalciumsignalingcan
inﬂuence neuronal functions and diseases (Xie, 2008). In the case
of the STREX exon of the BK channel, the regulated inclusion of
the exon is thought to ﬁne-tune the electrical activity of neurons
(Xie,2008). It has been shown that inclusion of the exon increases
thesensitivityoftheBKchannelstovoltageandcalcium,providing
a feedback loop regulatory mechanism (Li et al., 2007, 2009; Xie,
2008; and references therein). In the case of NMDAR1, the inclu-
sion or exclusion of exons 5 and 21 affects the localization and
membrane trafﬁcking of the NMDA receptor. This localization
and trafﬁcking in turn regulates the synaptic strength to stabilize
the neuronal ﬁring rate (homeostatic plasticity in neurons) (Lee
et al.,2007; Li et al.,2007; and references therein).
Treatment of neurons by various drugs increases intracellular
calcium levels by affecting calcium channels and pumps. Agonists
of NMDA receptors, such as NMDA, and glutamate can increase
calcium inﬂux through the NMDA receptors, whereas antago-
nists such as MK801 can inhibit the inﬂux of calcium through
NMDA receptors. Opening of L-type calcium channels can be
inhibited by use of pharmacological agents such as nifedipine,
nimodipine, and verapamil (Xie, 2008; Yoneyama et al., 2011;
Figure1). Thapsigargin increases intracellular calcium by inhibit-
ing the sarco/endoplasmic reticulum calcium pump, whereas use
of dantrolene can inhibit the release of the calcium from the
sarco/endoplasmic reticulum (Yoneyama et al., 2011)( Figure 1).
In addition to these two genes, it has been shown that increas-
ing calcium in the cell by using any of these pharmacological
agents affects the changes in splice site selection for many genes
(for a complete list see Table 1 in the review by Xie, 2008). Also,
an exon-array performed on human neuroblastoma IMR-32 cells
after depolarization with potassium chloride at different time
points or after treatment with thapsigargin identiﬁed a number
of genes that showed changes in splicing and transcript levels.
Splicing changes were observed in mRNAs of genes such as potas-
sium channels, neuroendocrine secretory proteins and metabolic
enzymes (McKee et al., 2007).
CALCIUM AND RNA ELEMENTS
It is thought that just like the RNA elements in exons and introns
where speciﬁc splicing regulators bind to regulate the inclusion
or skipping of the exon, there are speciﬁc short conserved RNA
sequences under the regulation of calcium. The current working
theory is that increased intracellular calcium levels result in the
activation of calcium/calmodulin-dependent kinase IV (CaMK
IV),whichregulatessplicesiteselectionthroughspeciﬁcRNAele-
mentsnamedCaMKIVresponsiveRNAelements(CaRREs)(Ares,
2007; Lee et al., 2007; Xie, 2008). Two such CaRRE sequences,
CACAUNRUUAU (N: any nucleotide, R: purine) and GUG-
GUAGA,havebeenidentiﬁed(Xieetal.,2005;Leeetal.,2007;Xie,
2008).Importantly,whentheseCaRREswereinsertedintoamini-
gene reporter, the mini-gene alternative splicing was regulated by
CaMK IV activity (Xie and Black, 2001; Xie et al., 2005; Lee et al.,
2007). Other than the CaRREs,a distinct UAGG motif in the pre-
mRNAhasbeenshowntoberequiredfordepolarization-mediated
splicing regulation. The UAGG motif-mediated splicing regula-
tion can be inhibited by KN93, a calcium/calmodulin-dependent
kinase inhibitor (An and Grabowski, 2007). In addition, KN93
and nifedipine, an L-type calcium channel blocker, were shown
to block the exclusion of the STREX exon (thought to be under
CaRRE control) caused by potassium chloride-mediated depolar-
ization (Xie and Black, 2001; Xie et al., 2005). Lastly, cerebella
of CaMK IV heterozygous mice showed increased STREX exon
inclusion (Xie et al., 2005).
The mechanism by which CaMK IV inﬂuences speciﬁc RNA
elements still remains an open question. One theory is that an
increase in the calcium level activates CaMK IV, which eventu-
ally regulates splicing through these speciﬁc RNA elements in the
pre-mRNA (CaRREs and UAGG). This is supported by the fact
that the observed changes in splicing after increases in the intra-
cellular calcium level can be inhibited in most of these cases by
the use of either CaMK inhibitors or by other inhibitors that
affect calcium levels in the cell [for a complete list see Table 1,
Xie,2008)]. Although the detailed molecular mechanisms remain
largely unknown on how CaMK levels inﬂuence splicing through
the CaRRE RNA elements, a hint came from the studies of the
UAGG motifs. In this case, hnRNP A1 was found to bind to these
speciﬁc motifs in pre-mRNA and eventually inﬂuence splice site
selection in neurons (An and Grabowski,2007). Subsequent stud-
ies demonstrated that hnRNP L is the splicing factor that binds to
a CaRRE RNA element inﬂuencing splice site selection (Yu et al.,
2009). This regulation of hnRNP L on the CaRRE1 RNA elements
wasfurthershowntobedependentonphosphorylationof hnRNP
L, which can be induced by CaMK IV as shown in in vitro assays
using hnRNP L and CaMK IV puriﬁed from mammalian cells (Yu
et al., 2009). A SELEX analysis indicated that a“CA”repeat motif
is sufﬁcient for the CaMK IV-mediated regulation of alternative
splicing through hnRNP L (Li et al.,2009).
Interestingly, the CaMK IV-hnRNP L cascade may also modu-
late alternative splicing of a non-neuronal gene, CD45 (PTPRC).
AlternativesplicingoftheCD45transcriptistightlyregulateddur-
ingBcelldevelopment.Inearlyperipherallymphocytes,exons4,5,
and6areincluded,whileatlaterstagesofBcelldevelopment,none
ofthethreeexonsareincluded(Ogimotoetal.,1993).Severalstud-
iesdemonstratedthatsplicingregulationof exons4and6ismedi-
ated by hnRNP L, polypyrimidine tract-binding protein (PTB)-
associated splicing factor (PSF), and hnRNP LL (Melton et al.,
2007; Topp et al., 2008). Treatment of early stages of B cells with
ionomycin, an ionophore which increases intracellular calcium,
led to skipping of all of these alternative exons (Ogimoto et al.,
1993). It remains to be determined whether there exist CaRRE
elementswherehnRNPLcouldpotentiallybindandregulatesplic-
ing of these exons. However,an exonic splicing silencer (ESS) that
has been identiﬁed to be bound by hnRNP L and PSF is indeed
CA-rich, similar to the CaRRE elements (Melton et al., 2007).
ItishighlylikelythatmanyadditionalcalciumresponsiveRNA
elements remain to be identiﬁed. The recently developed high-
throughput technologies will undoubtedly be very helpful in this
regard. Presumably,these elements are under the inﬂuence of cal-
cium signaling and can be bound by different splicing regulators
in regulation of the expression of the alternative exons with which
they are associated (Figure 1).
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CALCIUM AND SPLICING FACTORS
How does calcium signaling inﬂuence the expression of splicing
regulators themselves? Recent studies appear to reveal a theme for
thisregulation.Changesincalciumlevelsregulatecellularlocaliza-
tion of a number of RNA-binding proteins (RBPs). For example,
cortical neurons depolarized by treatment with potassium chlo-
ride were shown to have an increased localization of the splicing
factor hnRNPA1 in the nucleus (An and Grabowski, 2007). Inter-
estingly, for a number of RBPs, the change in cellular localization
is the consequence of regulated alternative splicing. A clear exam-
ple is Fox-1/A2BP1, where exon 19 inclusion is repressed when
neuronal cells are depolarized by potassium chloride (Lee et al.,
2009). The skipping of exon 19 causes a frame shift in the protein,
which leads to a more nuclear localization of Fox-1/A2BP1 pro-
tein (Lee et al., 2009). Recently, a genome-wide analysis of mice
with a central nervous system-speciﬁc gene depletion of Rbfox1
(A2BP1) revealed splicing changes in multiple transcripts that
encode proteins important for synaptic functions and neuronal
excitation (Gehman et al., 2011). Another example is exon III
of the Tra2beta1 transcript, which appears to be a more com-
plicated story. When rats were treated with pilocarpine, a drug
that functions as an agonist of muscarinic acetylcholine receptor
and elevates calcium levels in the cell, complex results that are
suggestive of a cell-speciﬁc differential response to calcium level
changes were obtained. The treatment led to a reduced inclusion
of exon 3 of Tra2beta1 in the hippocampus and increased inclu-
sioninthebraincortex(Daoudetal.,1999).Inasubsequentstudy
from the same group,it was shown that treatment of primary cor-
tical neurons with thapsigargin as well as pilocarpine increased
accumulation of the Tra2beta1 protein in the cytoplasm (Daoud
et al.,2002). Furthermore,translocation of Tra2beta1 to the cyto-
plasm was also observed in ischemic induction, which increases
the intracellular calcium levels. Interestingly, these treatments led
to splicing changes of a downstream target (Daoud et al., 2002).
Taken together, these studies strongly suggest that alterations in
intracellular calcium levels may alter the localization of many of
the spliceosomal components in neurons. Such changes can lead
to alterations in splice site selection of downstream target genes
that are regulated by these splicing factors.
Splicing change as a result of altered calcium level was also
observed with transcripts of other splicing factors. However, in
these cases, it is not clear if altered splicing leads to localiza-
tion changes of the resulting proteins. Intron 6 in the pre-mRNA
encoding Ania-6 (cyclin L1) was shown to be retained when cal-
cium levels were increased with the use of glutamate in striatal
neurons. Paradoxically, potassium chloride depolarization that
also increases calcium levels led to less intron retention (Berke
etal.,2001;Sgambatoetal.,2003).Furthermore,exon3of hnRNP
H3 and exon 2 of RNP-S1 were shown to be skipped when cor-
tical neurons were depolarized by potassium chloride (An and
Grabowski,2007).
CALCIUM LEVELS AFFECT SPLICING BY REGULATING
CHROMATIN MODIFIERS
Recently,variousstudieshaveindicatedthatcalciumsignalingcan
inﬂuence chromatin modiﬁcation,which in turn inﬂuences splice
site selection. For example, an increase in intracellular calcium
by depolarization using potassium chloride induces acetylation
of H2B in the hippocampus of rats (Maharana et al., 2010). The
elevated level of acetylation is reversed by addition of KN93, a
CaMK inhibitor, suggesting that the acetylation of H2B requires
CaMK (Maharana et al., 2010). The acetylation of H2B is also
blocked by U0126, a speciﬁc inhibitor targeting ERK phosphory-
lation, suggesting that the increased acetylation is dependent on
ERK phosphorylation. ERK is a known target for phosphoryla-
tion by CaMK; however, the mechanism by which ERK acetylates
H2B remains unknown (Maharana et al., 2010). Furthermore,
the treatment of rat hippocampal neurons with NMDA increases
calcium inﬂux, and activates the protein kinase A (PKA) or pro-
tein kinase C (PKC) pathway, which enhances ERK-dependent
acetylation of Histone H3 (Levenson et al., 2004; Chandramohan
et al., 2008). These data suggest that an increase in intracellu-
lar calcium levels can inﬂuence the acetylation levels of histones
(Figure 1).
Changes of acetylation levels of histones by intracellular cal-
cium signaling may lead to splicing pattern changes. It has been
shown that cells treated with trichostatin A (TSA), a potent
inhibitor of histone deacetylation, exhibit changes in mini-gene
splicing(Noguesetal.,2002).Inaddition,studiescarriedoutusing
yeast indicate that hyperacetylation of H3 by histone deacetylase
(HDAC) depletion can delay the release of U2 snRNP, and per-
turb the assembly of spliceosome components (Gunderson et al.,
2011). Recently an exon-array study showed that in HeLa cells
treated with sodium butyrate (NaB), a potent HDAC inhibitor,
683 genes showed changes in splice site selection, including Tau,
which is expressed in the central nervous system and associated
withfronto-temporaldementiaandParkinson’sdisease(Hnilicova
et al.,2011).
Depolarizationbypotassiumchlorideinduceshyperacetylation
of histones H3 and H4 globally in N2A cells and this hyper-
acetylation is reversed when cells are treated with normal media
suggesting that global hyperacetylation is a direct consequence of
increased intracellular calcium (Schor et al., 2009). This depo-
larization and recovery coincide with the alternative splicing of
NCAM exon 18, which is skipped when cells are depolarized and
included after recovery (Schor et al., 2009). ChIP studies showed
anincreaseinH3K9acintheintragenicchromatinregionbetween
exons 17 and 19 in response to depolarization (Schor et al.,2009).
Thesedatasuggestthathyperacetylationof histonesinresponseto
increasesincalciumaffectsthesplicesiteselectionof exon18.This
ideawasfurthersupportedbytheuseof TSA,whichmimickedthe
results of depolarization (Schor et al., 2009).
H3K36-Me3 marks have been shown to differ at constitutive
and alternative exons. H3K36-Me3 marks are found at the 5  ends
of the exons and enrichment of these methyl marks correlates
with increases in alternative exon inclusion (Hon et al., 2009;
Kolasinska-Zwierz et al., 2009). H3K36-Me3 can recruit PTB, a
splicing regulator,to the pre-mRNA through the chromatin bind-
ing protein MRG15 (Luco et al., 2010). Recruitment of splicing
machinery at a weak alternative splice site assists in the inclusion
of the weak exon (Allo et al.,2011; Luco et al.,2011). Calcium sig-
naling could also affect methylation of this histone mark,as it was
shown that depolarization by potassium chloride also increases
H3K36-Me3 at distal exons of the NCAM gene in hippocampal
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neurons, but the mechanism by which calcium signaling achieves
this is not clear (Schor et al., 2009).
Data obtained from these studies indicate that an increase in
calcium signaling could affect chromatin modiﬁcations, which
may inﬂuence alternative splicing. It is tempting to speculate that
in addition to the direct effects on RBPs, this might be another
mechanism by which calcium regulates alternative splicing in
neurons indirectly (Figure 1).
An intriguing new study demonstrates that exon 5 splicing of
CD45 pre-mRNA is modulated during development as a conse-
quenceof chromatinmodiﬁcation(Shuklaetal.,2011).Thisstudy
shows that CTCF,a zinc-ﬁnger DNA binding protein,binds to the
exon 5 region of the CD45 gene, slowing down transcription by
providingapausingof RNAPolII.Thisallowsforexon5inclusion
at the early stages of lymphocyte development. During matura-
tion of lymphocytes,CTCF binding is perturbed due to increased
methylation on DNA in a region where CTCF binds to exon 5,
leadingtoexon5skipping(Shuklaetal.,2011).Giventhatexpres-
sion of exon 5 of CD45 was shown to respond to cellular calcium
level changes, it will be interesting to investigate whether calcium
signaling affects the methylation status of DNA at exon 5,thereby
modulating the splicing of exon 5 of the CD45 pre-mRNA.
PERSPECTIVE
All of the studies discussed above point in the direction that
changes in calcium signaling can play a major role in alternative
splicing in neurons and other cell types. This could possibly
be a molecular mechanism by which cells control the dynamic
expression of exons that are important for their development
and function. The calcium levels in neurons are under “home-
ostatic control” and disruption of the normal calcium level in
neurons leads to disruption of neuronal functions and disease
development (reviewed in Marambaud et al., 2009). Genome-
wide exon arrays are now available and could be a useful tool
in identifying the groups of genes whose alternative splicing is
regulated by calcium signaling. With the advent of newer tech-
niques like deep sequencing and genome-wide siRNA libraries
with the augmentation of bioinformatic tools, it is time to study
the effect of calcium-regulated alternative splicing and its role
in physiological development and disease states at the genome-
wide level. It is conceivable that expression of many alternative
exons is subject to calcium signaling and that the dynamic reg-
ulation of these exons involves numerous distinct RNA elements
and RBPs that interact with these RNA elements. Rules of cal-
cium signaling-regulated alternative splicing will emerge from
genome-wide studies.
ACKNOWLEDGMENTS
WethankJiuyongXie(Universityof Manitoba)forcriticalreading
of the manuscript. We thank Melissa N. Hinman and Victoria A.
Fleming for helpful discussion and editing. Hua Lou is supported
by a NIH grant (NS-049103).
REFERENCES
Allo, M., Schor, I. E., Munoz, M. J.,
de la Mata, M., Agirre, E., Val-
carcel, J., Eyras, E., and Korn-
blihtt, A. R. (2011). Chromatin
and alternative splicing. Cold Spring
Harb. Symp. Quant. Biol. 75,
103–111.
Alonso, M. T., and Garcia-Sancho, J.
(2011). Nuclear Ca(2+) signalling.
Cell Calcium 49, 280–289.
An, P., and Grabowski, P. J. (2007).
Exon silencing by UAGG motifs
in response to neuronal excitation.
PLoS Biol. 5, e36. doi:10.1371/jour-
nal.pbio.0050036
Ares, M. Jr. (2007). Sing the genome
electric: excited cells adjust
their splicing. PLoS Biol. 5, e55.
doi:10.1371/journal.pbio.0050055
Bentley, D. L. (2005). Rules of engage-
ment: co-transcriptional recruit-
ment of pre-mRNA processing fac-
tors. Curr. Opin. Cell Biol. 17,
251–256.
Berget, S. M. (1995). Exon recognition
in vertebrate splicing. J. Biol. Chem.
270, 2411–2414.
Berke, J. D., Sgambato, V., Zhu, P.
P., Lavoie, B., Vincent, M., Krause,
M., and Hyman, S. E. (2001).
Dopamine and glutamate induce
distinctstriatalspliceformsof Ania-
6, an RNA polymerase II-associated
cyclin. Neuron 32, 277–287.
Berridge, M. J. (1998). Neuronal cal-
cium signaling. Neuron 21, 13–26.
Berridge,M.J.(2009).Calciumhypoth-
esis of Alzheimer’s disease. Pﬂugers
Arch. 459, 441–449.
Black, D. L. (2003). Mechanisms
of alternative pre-messenger RNA
splicing. Annu. Rev. Biochem. 72,
291–336.
Black,D.L.,andGrabowski,P.J.(2003).
Alternative pre-mRNA splicing and
neuronal function. Prog. Mol. Sub-
cell. Biol. 31, 187–216.
Brodsky,A. S.,Meyer,C.A.,Swinburne,
I. A., Hall, G., Keenan, B. J., Liu,
X. S., Fox, E. A., and Silver, P. A.
(2005). Genomic mapping of RNA
polymerase II reveals sites of co-
transcriptional regulation in human
cells. Genome Biol. 6, R64.
Chandramohan, Y., Droste, S. K.,
Arthur, J. S., and Reul, J. M.
(2008). The forced swimming-
induced behavioural immobility
response involves histone H3
phospho-acetylation and c-Fos
induction in dentate gyrus gran-
ule neurons via activation of the
N-methyl-D-aspartate/extracellular
signal-regulated kinase/mitogen-
and stress-activated kinase sig-
nalling pathway. Eur. J. Neurosci. 27,
2701–2713.
Daoud, R., Da Penha Berzaghi, M.,
Siedler,F.,Hubener,M.,and Stamm,
S. (1999). Activity-dependent regu-
lationof alternativesplicingpatterns
in the rat brain. Eur. J. Neurosci. 11,
788–802.
Daoud, R., Mies, G., Smialowska, A.,
Olah, L., Hossmann, K. A., and
Stamm, S. (2002). Ischemia induces
a translocation of the splicing fac-
tor tra2-beta 1 and changes alterna-
tive splicing patterns in the brain. J.
Neurosci. 22, 5889–5899.
Egloff,S.,andMurphy,S.(2008).Crack-
ing the RNA polymerase II CTD
code. Trends Genet. 24, 280–288.
Eperon,L.P.,Graham,I.R.,Grifﬁths,A.
D., and Eperon, I. C. (1988). Effects
ofRNAsecondarystructureonalter-
nativesplicingofpre-mRNA:isfold-
ing limited to a region behind the
transcribing RNA polymerase? Cell
54, 393–401.
Gehman, L. T., Stoilov, P., Maguire, J.,
Damianov, A., Lin, C. H., Shiue,
L., Ares, M. Jr., Mody, I., and
Black, D. L. (2011). The splic-
ing regulator Rbfox1 (A2BP1) con-
trols neuronal excitation in the
mammalian brain. Nat. Genet. 43,
706–711.
Grosso, A. R., Gomes, A. Q., Barbosa-
Morais, N. L., Caldeira, S., Thorne,
N.P.,Grech,G.,vonLindern,M.,and
Carmo-Fonseca, M. (2008). Tissue-
speciﬁc splicing factor gene expres-
sionsignatures.NucleicAcidsRes.36,
4823–4832.
Gunderson,F. Q.,Merkhofer,E. C.,and
Johnson, T. L. (2011). Dynamic his-
toneacetylationiscriticalforcotran-
scriptional spliceosome assembly
and spliceosomal rearrangements.
Proc. Natl. Acad. Sci. U.S.A. 108,
2004–2009.
Han, K., Yeo, G., An, P., Burge, C.
B., and Grabowski, P. J. (2005).
A combinatorial code for splicing
silencing:UAGG and GGGG motifs.
PLoS Biol. 3,e158. doi:10.1371/jour-
nal.pbio.0030158
Hirose, Y., and Manley, J. L. (2000).
RNA polymerase II and the integra-
tionofnuclearevents.GenesDev.14,
1415–1429.
Hnilicova, J., Hozeiﬁ, S., Duskova,
E., Icha, J., Tomankova, T., and
Stanek, D. (2011). Histone deacety-
lase activity modulates alternative
splicing. PLoS ONE 6, e16727.
doi:10.1371/journal.pone.0016727
Hon, G., Wang, W., and Ren, B.
(2009).Discoveryandannotationof
functional chromatin signatures in
the human genome. PLoS Comput.
Biol. 5, e1000566. doi:10.1371/jour-
nal.pcbi.1000566
Jurica, M. S., and Moore, M. J. (2003).
Pre-mRNA splicing: awash in a sea
of proteins. Mol. Cell 12, 5–14.
Kaplan, C. D. (2009). Revealing the
hidden relationship between nucle-
osomes and splicing. Cell Cycle 8,
3633–3634.
Kolasinska-Zwierz, P., Down, T.,
Latorre, I., Liu, T., Liu, X. S., and
Ahringer, J. (2009). Differential
chromatin marking of introns and
expressedexonsbyH3K36me3. Nat.
Genet. 41, 376–381.
www.frontiersin.org December 2011 | Volume 5 | Article 141 | 5Sharma and Lou Depolarization and alternative splicing
Kornblihtt, A. R. (2005). Promoter
usage and alternative splicing. Curr.
Opin. Cell Biol. 17, 262–268.
Kornblihtt, A. R., Schor, I. E., Allo,
M., and Blencowe, B. J. (2009).
When chromatin meets splicing.
Nat. Struct. Mol. Biol. 16, 902–903.
Lee, J. A., Tang, Z. Z., and Black, D.
L. (2009). An inducible change in
Fox-1/A2BP1splicingmodulatesthe
alternative splicing of downstream
neuronaltargetexons.GenesDev.23,
2284–2293.
Lee, J. A., Xing, Y., Nguyen, D., Xie,
J., Lee, C. J., and Black, D. L.
(2007). Depolarization and CaM
kinase IV modulate NMDA recep-
tor splicing through two essential
RNA elements. PLoS Biol. 5, e40.
doi:10.1371/journal.pbio.0050040
Levenson,J.M.,O’Riordan,K.J.,Brown,
K. D., Trinh, M. A., Molfese, D. L.,
and Sweatt, J. D. (2004). Regulation
of histone acetylation during mem-
ory formation in the hippocampus.
J. Biol. Chem. 279, 40545–40559.
Lewis, J. D., and Tollervey, D. (2000).
Like attracts like: getting RNA pro-
cessing together in the nucleus. Sci-
ence 288, 1385–1389.
Li,H.,Liu,G.,Yu,J.,Cao,W.,Lobo,V.G.,
and Xie, J. (2009). In vivo selection
of kinase-responsive RNA elements
controlling alternative splicing. J.
Biol. Chem. 284, 16191–16201.
Li, Q., Lee, J. A., and Black, D. L.
(2007).Neuronalregulationofalter-
native pre-mRNA splicing. Nat. Rev.
Neurosci. 8, 819–831.
Luco,R.F.,Allo,M.,Schor,I.E.,Kornbli-
htt,A.R.,andMisteli,T.(2011).Epi-
genetics in alternative pre-mRNA
splicing. Cell 144, 16–26.
Luco, R. F., Pan, Q., Tominaga, K.,
Blencowe,B.J.,Pereira-Smith,O.M.,
and Misteli,T. (2010). Regulation of
alternative splicing by histone mod-
iﬁcations. Science 327, 996–1000.
Maharana, C., Sharma, K. P., and
Sharma,S.K.(2010).Depolarization
induces acetylation of histone H2B
in the hippocampus. Neuroscience
167, 354–360.
Marambaud,P.,Dreses-Werringloer,U.,
and Vingtdeux, V. (2009). Cal-
cium signaling in neurodegenera-
tion. Mol. Neurodegener. 4, 20.
McKee, A. E., Neretti, N., Carvalho,
L. E., Meyer, C. A., Fox, E. A.,
Brodsky, A. S., and Silver, P. A.
(2007). Exon expression proﬁling
reveals stimulus-mediated exon use
inneuralcells.GenomeBiol.8,R159.
Melton, A. A., Jackson, J., Wang, J., and
Lynch, K. W. (2007). Combinator-
ial control of signal-induced exon
repression by hnRNP L and PSF.
Mol. Cell. Biol. 27, 6972–6984.
Misteli, T., and Spector, D. L. (1999).
RNA polymerase II targets pre-
mRNA splicing factors to transcrip-
tion sites in vivo. Mol. Cell 3,
697–705.
Nogues, G., Kadener, S., Cramer, P.,
Bentley, D., and Kornblihtt, A. R.
(2002). Transcriptional activators
differ in their abilities to control
alternative splicing. J. Biol. Chem.
277, 43110–43114.
Ogimoto,M.,Katagiri,T.,Hasegawa,K.,
Mizuno, K., and Yakura, H. (1993).
Induction of CD45 isoform switch
inmurineBcellsbyantigenreceptor
stimulation and by phorbol myris-
tate acetate and ionomycin. Cell.
Immunol. 151, 97–109.
Pan,Q.,Shai,O.,Lee,L.J.,Frey,B.J.,and
Blencowe,B. J. (2008). Deep survey-
ing of alternative splicing complex-
ity in the human transcriptome by
high-throughput sequencing. Nat.
Genet. 40, 1413–1415.
Phatnani, H. P., Jones, J. C., and
Greenleaf, A. L. (2004). Expand-
ing the functional repertoire of
CTD kinase I and RNA polymerase
II: novel phosphoCTD-associating
proteins in the yeast proteome. Bio-
chemistry 43, 15702–15719.
Piacentini, L., Fanti, L., Negri, R.,
Del Vescovo, V., Fatica, A.,
Altieri, F., and Pimpinelli, S.
(2009). Heterochromatin protein
1 (HP1a) positively regulates
euchromatic gene expression
through RNA transcript association
and interaction with hnRNPs in
Drosophila.PLoSGenet.5,e1000670.
doi:10.1371/journal.pgen.1000670
Rosonina,E.,andBlencowe,B.J.(2004).
Analysisof therequirementforRNA
polymerase II CTD heptapeptide
repeats in pre-mRNA splicing and
3’-end cleavage. RNA 10, 581–589.
Schor, I. E., Allo, M., and Kornblihtt,
A. R. (2010). Intragenic chromatin
modiﬁcations:anewlayerinalterna-
tive splicing regulation. Epigenetics
5, 174–179.
Schor, I. E., Rascovan, N., Pelisch, F.,
Allo, M., and Kornblihtt, A. R.
(2009).Neuronalcelldepolarization
induces intragenic chromatin modi-
ﬁcationsaffectingNCAMalternative
splicing. Proc. Natl. Acad. Sci. U.S.A.
106, 4325–4330.
Sgambato, V., Minassian, R., Nairn,
A. C., and Hyman, S. E. (2003).
Regulation of ania-6 splice variants
by distinct signaling pathways in
striatal neurons. J. Neurochem. 86,
153–164.
Shukla, S., Kavak, E., Gregory, M.,
Imashimizu, M., Shutinoski, B.,
Kashlev, M., Oberdoerffer, P., Sand-
berg,R.,andOberdoerffer,S.(2011).
CTCF-promoted RNA polymerase
IIpausinglinksDNAmethylationto
splicing. Nature 479, 74–79.
Sims, R. J. III, Millhouse, S., Chen, C.
F.,Lewis,B.A.,Erdjument-Bromage,
H., Tempst, P., Manley, J. L., and
Reinberg, D. (2007). Recognition of
trimethylated histone H3 lysine 4
facilitates the recruitment of tran-
scription postinitiation factors and
pre-mRNA splicing. Mol. Cell 28,
665–676.
Spies, N., Nielsen, C. B., Padgett, R. A.,
andBurge,C.B.(2009).Biasedchro-
matinsignaturesaroundpolyadeny-
lation sites and exons. Mol. Cell 36,
245–254.
Topp,J.D.,Jackson,J.,Melton,A.A.,and
Lynch, K. W. (2008). A cell-based
screen for splicing regulators iden-
tiﬁes hnRNP LL as a distinct signal-
induced repressor of CD45 variable
exon 4. RNA 14, 2038–2049.
Wang, E. T., Sandberg, R., Luo, S.,
Khrebtukova, I., Zhang, L., Mayr,
C., Kingsmore, S. F., Schroth, G. P.,
and Burge, C. B. (2008). Alterna-
tive isoform regulation in human
tissue transcriptomes. Nature 456,
470–476.
West, A. E., Chen, W. G., Dalva,
M. B., Dolmetsch, R. E., Korn-
hauser,J. M.,Shaywitz,A. J.,Takasu,
M. A., Tao, X., and Greenberg,
M. E. (2001). Calcium regula-
tion of neuronal gene expression.
Proc. Natl. Acad. Sci. U.S.A. 98,
11024–11031.
Xie, J. (2008). Control of alternative
pre-mRNA splicing by Ca(++) sig-
nals. Biochim. Biophys. Acta 1779,
438–452.
Xie,J.,and Black,D. L. (2001).A CaMK
IV responsive RNA element medi-
atesdepolarization-inducedalterna-
tive splicing of ion channels. Nature
410, 936–939.
Xie, J., Jan, C., Stoilov, P., Park, J.,
and Black, D. L. (2005). A con-
sensus CaMK IV-responsive RNA
sequence mediates regulation of
alternative exons in neurons. RNA
11, 1825–1834.
Yoneyama, M., Kawada, K., Shiba,
T., and Ogita, K. (2011). Endoge-
nous nitric oxide generation linked
to ryanodine receptors activates
cyclic GMP/protein kinase G path-
way for cell proliferation of neural
stem/progenitor cells derived from
embryonic hippocampus. J. Phar-
macol. Sci. 115, 182–195.
Yu, J., Hai, Y., Liu, G., Fang, T., Kung,
S. K., and Xie, J. (2009). The het-
erogeneous nuclear ribonucleopro-
tein L is an essential component
in the Ca2+/calmodulin-dependent
protein kinase IV-regulated alter-
native splicing through cytidine-
adenosinerepeats.J.Biol.Chem.284,
1505–1513.
Zhang, S. J., Zou, M., Lu, L., Lau, D.,
Ditzel, D. A., Delucinge-Vivier, C.,
Aso, Y., Descombes, P., and Bad-
ing, H. (2009). Nuclear calcium
signaling controls expression of a
large gene pool: identiﬁcation of
a gene program for acquired neu-
roprotection induced by synaptic
activity. PLoS Genet. 5, e1000604.
doi:10.1371/journal.pgen.1000604
Zhou, H. L., Hinman, M. N., Barron,
V. A., Geng, C., Zhou, G., Luo, G.,
Siegel,R. E.,and Lou,H. (2011). Hu
proteins regulate alternative splicing
by inducing localized histone hyper-
acetylation in an RNA-dependent
manner. Proc. Natl. Acad. Sci. U.S.A.
108, E627–E635.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 03 November 2011; paper
pending published: 23 November 2011;
accepted: 06 December 2011; published
online: 27 December 2011.
Citation: Sharma A and Lou H (2011)
Depolarization-mediated regulation of
alternative splicing. Front. Neurosci.
5:141. doi: 10.3389/fnins.2011.00141
This article was submitted to Frontiers in
Neurogenomics,aspecialtyofFrontiersin
Neuroscience.
Copyright © 2011 Sharma and Lou.This
isanopen-accessarticledistributedunder
thetermsoftheCreativeCommonsAttri-
bution Non Commercial License, which
permits non-commercial use, distribu-
tion, and reproduction in other forums,
provided the original authors and source
are credited.
Frontiers in Neuroscience | Neurogenomics December 2011 | Volume 5 | Article 141 | 6